中国同辐2025年度报告

（於中華人民共和國註冊成立的股份有限公司）(A joint stock company incorporated in thePeople’s Republic of China with limited liability)股份代號Stock Code：1763 CONTENTS Corporate Profile2Corporate Information4Definitions9Chairman’s Statement13Highlights of the Year17Development Status of the Nuclear TechnologyApplication Industry25Financial Highlights28Management Discussion and Analysis29Corporate Governance Report75Biographies - Directors and Senior Management106Report of the Directors116Independent Auditor’s Report171Consolidated Statement of Profit or Loss179Consolidated Statement of Comprehensive Income180Consolidated Statement of Financial Position181Consolidated Statement of Changes in Equity183Consolidated Statement of Cash Flows185Notes to Consolidated Financial Statements188Five Year Summary355 CORPORATE PROFILE 1 7 6 31 9 8 33,57820251231201876 Founded in 1983, China Isotope & Radiation Corporation (stockcode:1763,“CIRC”)is a leading enterprise in isotope andirradiation application in the PRC with 3,578 employees (as of 31December 2025), and was listed on the Main Board of the StockExchange on 6 July 2018. As a controlling subsidiary of ChinaNational Nuclear Corporation (“CNNC”), CIRC is tasked with thedualmission of building a“strong nuclear power nation”andcontributing to “healthy China”. It is the pioneer and main force ofnuclear technology application industry in China. With 43 years of experience in the nuclear technology applicationindustry,CIRC is the leading nuclear technology applicationenterprisein China,integrating research and development,production,sales and services,and is also a high-techenterprisewith the most abundant products and the mostcomplete industrial chain in the field of isotope and its productsandirradiation processing in the world.Focusing on the twomajorindustrial directions of nuclear healthcare and irradiationapplication, CIRC is committed to providing integrated solutionsfornuclear medicine and radiotherapy,as well as radiationtechnology promotion and application, forming a “6+N” industriallayout with six major businesses as the core, including nuclides,nuclearmedicines,nuclear medical equipment,integratedsolution for nuclear medicine, radioactive source and application,and irradiation application. CIRC is the largest manufacturer ofimagingdiagnostic and therapeutic radiopharmaceuticals,UreaBreath Test (UBT) kits and analyzers in China; the largest andmostcomplete manufacturer of radioactive sources in China;andthe only service provider in China that covers the entireprocessof site selection,design,construction,source supplyand decommissioning of irradiation stations. CIRC has enteredthe field of high-end radiotherapy equipment in cooperation withone of the world’s top three radiotherapy equipment suppliers,U.S. Accuray, focusing on the introduction, digestion, absorptionandre-innovation of high-end radiotherapy equipment,suchasTomoTherapy system and radiosurgery robots.Throughindependentinnovation,it has successfully developed a newfully domesticated intelligent Cobalt-60 Gamma-ray StereotacticRadiotherapy System (Gamma Knife). CIRC is the only enterprisein China with a complete industrial chain of “source, equipment,station and application” for irradiation application, with the thirdlargest industrial scale in China. 4366+N-60 CORPORATE PROFILE(CONTINUED) 202512313771.87,00042023TomoC As of 31 December 2025, the Company has formed a network of37 medical centers, with 7 R&D and production bases, servingmore than 18,000 medical institutions, serving nearly 70 millionpeople annually, and supplying more than 40,000 sets of ancillaryradioactivesource equipment.In 2023,Tomo C,a new typeoffirst domestic double helix tomotherapy product in China’shigh-end healthcare field, was independently produced in largequantities. In recent years, CIRC has accounted for nearly 70% ofthe large-scale Class A radiotherapy equipment approved to beequipped by the National Health Commission, making it the No. 1brand of Class A radiotherapy equipment. 6+N Lookingforward,CIRC will focus on strengthening its corefunctionsand enhancing its core competitiveness,focusingon playing the “three roles” and striving to be the “three front-runners”, making continuous improvements, pursuing excellence,andcomprehensively promoting the“6+N”industrial layoutofnuclides,nuclear medicines,nuclear medical equipment,integrated solution for nuclear medicine, radioactive source andapplication,and irradiation application,with a view to buildingCIRC into a world-class nuclear technology application productand service provider. CHINA ISOTOPE & RADIATION CORPORATION CORPORATE INFORMATION LEGAL NAME OF THE COMPANY (Abbreviation:) ENGLISH NAME OF THE COMPANY China Isotope & Radiation Corporation* China Isotope & Radiation Corporation* REGISTERED OFFICE 661418 Room 418, South 4th FloorBuilding 1, No. 66 Changwa Middle StreetHaidian DistrictBeijing, the PRC HEAD OFFICE IN THE PRC 66 No. 66 Changwa Middle StreetHaidian Dis